iShares U.S. Pharmaceuticals ETF Rating $68.92 -0.17 (-0.25%) (As of 11/1/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy2.66Holdings in IHE have an aggregate rating of Moderate Buy based on 302 analyst ratings issued in the past year covering 38 companies (99.9% of the portfolio).IHE Aggregate Price Target$85.5424.12% UpsideHigh Prediction$104.84Average Prediction$85.54Low Prediction$66.84Holdings in IHE have an aggregate price target of $85.54 and a range of $66.84 to $104.84 covering 38 companies (99.9% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings22.22%JNJJohnson & Johnson$160.13+0.2%4.8841 of 5 stars2.54$175.93 9.9%13Short Interest ↓22.07%LLYEli Lilly and Company$818.93-1.3%4.9036 of 5 stars2.84$1,009.00 23.2%19Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision4.87%BMYBristol-Myers Squibb$54.32-2.6%4.5139 of 5 stars1.93$53.00 -2.4%14Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage4.59%VTRSViatris$11.62+0.2%2.5561 of 5 stars2.50$14.00 20.5%2Upcoming Earnings4.37%PFEPfizer$28.09-0.7%4.9889 of 5 stars2.60$33.58 19.6%15Earnings ReportAnalyst UpgradeAnalyst Revision4.31%ZTSZoetis$181.95+1.8%4.907 of 5 stars3.10$221.44 21.7%10Upcoming Earnings4.24%CTLTCatalent$58.73+0.2%3.1186 of 5 stars2.00$59.83 1.9%84.14%RPRXRoyalty Pharma$27.10+0.4%4.7659 of 5 stars2.83$41.67 53.8%6Upcoming Earnings4.13%MRKMerck & Co., Inc.$101.88-0.4%4.9993 of 5 stars2.88$129.93 27.5%17Earnings ReportAnalyst ForecastNews Coverage2.95%ITCIIntra-Cellular Therapies$86.54+2.1%4.6002 of 5 stars2.85$96.62 11.6%13Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage2.68%JAZZJazz Pharmaceuticals$110.45+0.4%4.7878 of 5 stars2.79$173.43 57.0%14Upcoming Earnings2.43%ELANElanco Animal Health$12.60-0.3%4.1802 of 5 stars2.43$17.00 34.9%7Upcoming EarningsShort Interest ↓1.75%OGNOrganon & Co.$18.07-3.8%4.7021 of 5 stars2.50$21.33 18.1%4Dividend AnnouncementNews Coverage1.74%CORTCorcept Therapeutics$47.62-2.8%4.9202 of 5 stars3.00$65.25 37.0%5Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.44%AXSMAxsome Therapeutics$88.84-0.2%4.7231 of 5 stars3.00$124.64 40.3%141.43%PBHPrestige Consumer Healthcare$74.05+0.4%4.4328 of 5 stars2.60$94.20 27.2%5Upcoming EarningsNews CoveragePositive News1.36%PRGOPerrigo$26.09+1.8%4.9043 of 5 stars2.75$37.00 41.8%4Upcoming EarningsDividend Announcement0.81%LGNDLigand Pharmaceuticals$110.04+4.1%4.847 of 5 stars3.00$132.83 20.7%6Upcoming EarningsAnalyst ForecastNews Coverage0.81%EWTXEdgewise Therapeutics$34.00+1.3%2.0142 of 5 stars3.00$35.60 4.7%5Short Interest ↓Positive News0.76%AMPHAmphastar Pharmaceuticals$50.73+0.4%4.6389 of 5 stars2.50$63.00 24.2%4Analyst DowngradePositive News0.74%SUPNSupernus Pharmaceuticals$33.97-0.3%1.7799 of 5 stars2.50$36.00 6.0%2Upcoming EarningsHigh Trading Volume0.66%ARVNArvinas$26.90+1.8%2.0922 of 5 stars2.87$56.92 111.6%15Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage0.54%TARSTarsus Pharmaceuticals$47.30+6.3%0.758 of 5 stars3.00$51.60 9.1%7High Trading Volume0.49%AMRXAmneal Pharmaceuticals$8.49+0.2%3.1805 of 5 stars2.80$9.40 10.7%5Upcoming EarningsShort Interest ↓0.47%SAVACassava Sciences$26.21+1.6%3.7252 of 5 stars3.00$111.50 325.4%2Upcoming EarningsNews Coverage0.44%COLLCollegium Pharmaceutical$33.46-2.0%4.1051 of 5 stars2.60$42.60 27.3%5Upcoming EarningsPositive News0.43%INVAInnoviva$19.26-1.5%1.5257 of 5 stars3.001Upcoming Earnings0.41%HRMYHarmony Biosciences$33.08+3.0%4.9008 of 5 stars2.56$47.00 42.1%9Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume0.40%NMRANeumora Therapeutics$11.17-2.4%2.0114 of 5 stars2.86$22.83 104.4%7Upcoming EarningsPositive News0.38%ANIPANI Pharmaceuticals$58.19+1.7%4.8195 of 5 stars2.83$77.33 32.9%6Short Interest ↓0.33%ELVNEnliven Therapeutics$27.63-0.8%1.2112 of 5 stars3.25$34.33 24.3%4Insider Selling0.31%PCRXPacira BioSciences$16.57-0.2%4.8163 of 5 stars2.20$24.20 46.0%10Upcoming EarningsNews Coverage0.30%PLRXPliant Therapeutics$14.52+3.2%3.8876 of 5 stars3.11$40.57 179.4%90.23%PHATPhathom Pharmaceuticals$18.27+6.5%1.1561 of 5 stars2.75$22.50 23.2%4Upcoming EarningsNews Coverage0.18%MNMDMind Medicine (MindMed)$6.14-2.5%1.9519 of 5 stars3.25$25.38 313.3%12Upcoming Earnings0.17%RVNCRevance Therapeutics$5.80-1.7%4.4566 of 5 stars2.11$10.29 77.3%9Analyst ForecastNews Coverage0.15%NUVBNuvation Bio$2.30+4.1%3.8148 of 5 stars3.00$6.40 178.3%5Upcoming Earnings0.12%TBPHTheravance Biopharma$8.28+0.5%2.525 of 5 stars2.40$13.75 66.1%5Positive NewsGap Up This page (NYSEARCA:IHE) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
